ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 09/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. OGEN, ORGS, XBIO, INM, CMND, ONCO, JAGX, PWUP, TRIB, and REVBShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include Oragenics (OGEN), Orgenesis (ORGS), Xenetic Biosciences (XBIO), InMed Pharmaceuticals (INM), Clearmind Medicine (CMND), Onconetix (ONCO), Jaguar Animal Health (JAGX), PowerUp Acquisition (PWUP), Trinity Biotech (TRIB), and Revelation Biosciences (REVB). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. Its Competitors Oragenics Orgenesis Xenetic Biosciences InMed Pharmaceuticals Clearmind Medicine Onconetix Jaguar Animal Health PowerUp Acquisition Trinity Biotech Revelation Biosciences Oragenics (NYSE:OGEN) and ASLAN Pharmaceuticals (NASDAQ:ASLN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, risk and institutional ownership. Which has more risk and volatility, OGEN or ASLN? Oragenics has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, ASLAN Pharmaceuticals has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Is OGEN or ASLN more profitable? Oragenics' return on equity of -2,087.95% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets OragenicsN/A -2,087.95% -486.56% ASLAN Pharmaceuticals N/A -8,454.87%-121.60% Which has stronger earnings and valuation, OGEN or ASLN? Oragenics has higher earnings, but lower revenue than ASLAN Pharmaceuticals. Oragenics is trading at a lower price-to-earnings ratio than ASLAN Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOragenicsN/AN/A-$20.66M-$21.42-0.06ASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03 Do insiders and institutionals believe in OGEN or ASLN? 18.7% of Oragenics shares are owned by institutional investors. Comparatively, 58.8% of ASLAN Pharmaceuticals shares are owned by institutional investors. 10.1% of Oragenics shares are owned by insiders. Comparatively, 4.7% of ASLAN Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer OGEN or ASLN? In the previous week, Oragenics had 1 more articles in the media than ASLAN Pharmaceuticals. MarketBeat recorded 1 mentions for Oragenics and 0 mentions for ASLAN Pharmaceuticals. ASLAN Pharmaceuticals' average media sentiment score of 0.00 beat Oragenics' score of -1.00 indicating that ASLAN Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Oragenics Negative ASLAN Pharmaceuticals Neutral SummaryASLAN Pharmaceuticals beats Oragenics on 6 of the 11 factors compared between the two stocks. Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$934.71M$5.87B$10.14BDividend YieldN/A4.84%5.68%4.59%P/E Ratio-0.031.1074.5225.93Price / Sales0.1026.70548.33126.97Price / CashN/A19.5637.5660.44Price / Book-0.096.6912.166.29Net Income-$44.22M-$4.50M$3.28B$270.77M7 Day PerformanceN/A8.75%0.87%3.88%1 Month PerformanceN/A9.50%4.96%4.88%1 Year PerformanceN/A22.47%60.74%26.01% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330OGENOragenics0.1993 of 5 stars$1.17-0.4%N/A-91.9%$4.81MN/A-0.165Short Interest ↑ORGSOrgenesisN/A$1.00+525.0%N/AN/A$4.80M$662K0.00150Gap UpXBIOXenetic Biosciences1.3148 of 5 stars$3.05-0.2%N/A-6.5%$4.69M$2.50M-1.524Gap DownINMInMed Pharmaceuticals1.295 of 5 stars$2.25+4.7%N/A-61.9%$4.50M$4.60M-0.1910Positive NewsShort Interest ↓Gap DownCMNDClearmind Medicine1.4252 of 5 stars$1.03+2.2%N/A-22.7%$4.41MN/A-0.94N/AEarnings ReportUpcoming EarningsShort Interest ↓Gap UpONCOOnconetix0.9103 of 5 stars$2.78+3.7%N/A-99.3%$4.30M$1.33M0.0012JAGXJaguar Animal Health1.6167 of 5 stars$1.93-2.5%$60.00+3,008.8%-92.9%$4.19M$11.69M0.0050Short Interest ↑PWUPPowerUp AcquisitionN/A$0.510.0%N/A-96.1%$3.97MN/A0.00N/AGap UpHigh Trading VolumeTRIBTrinity Biotech1.7313 of 5 stars$1.10-1.8%N/A-85.4%$3.97M$61.56M-0.08480Short Interest ↓Gap DownREVBRevelation Biosciences0.858 of 5 stars$2.33-17.4%N/A-95.6%$3.96MN/A-0.0310News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies OGEN Alternatives ORGS Alternatives XBIO Alternatives INM Alternatives CMND Alternatives ONCO Alternatives JAGX Alternatives PWUP Alternatives TRIB Alternatives REVB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASLN Stock Alerts